Cutaneous reactions with enfortumab vedotin: A case series and review of the literature
Saved in:
Main Authors: | Allison S. Dobry, MD (Author), Cesar Antonio Virgen, MD, PhD (Author), Anna-Marie Hosking, MD (Author), Nataliya Mar, MD (Author), Linda Doan, MD, PhD (Author), Bonnie Lee, MD (Author), Janellen Smith, MD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Desquamative extravasation reaction secondary to enfortumab vedotin
by: Akshay N. Pulavarty, MD, MPH, et al.
Published: (2024) -
Characterization of cutaneous adverse events to enfortumab vedotin: A retrospective case-control study
by: Ahmad Shahin, BS, et al.
Published: (2023) -
Enfortumab vedotin toxic epidermal necrolysis-like blistering dermatosis: A case series and review of the literature
by: Bushra Khanjar, MD, et al.
Published: (2024) -
Severe cutaneous drug toxicity following enfortumab vedotin treatment for metastatic urothelial carcinoma
by: Christina D. Enescu, BS, et al.
Published: (2022) -
Complete Pathologic Response With Pembrolizumab and Enfortumab Vedotin in Urothelial Carcinoma of the Upper Urinary Tract
by: Kok Hoe Chan MD, et al.
Published: (2024)